Investigation and management of anaemia

      Abstract

      Anaemia is not a disease but is a manifestation of some other process. Once a deficiency of iron, vitamin B12 and folic acid has been excluded, the anaemia may be secondary to another pathology, and causes such as infection, inflammation, neoplasia, drug or chemical exposure or an autoimmune disorder sought. The approach should be to obtain details of the patient’s personal and family history, ethnic origin, dietary and drug history and examination, and, to use simple laboratory tests to determine the type of anaemia. This will often provide a provisional diagnosis, and can be confirmed by measurements of iron, vitamin B12 and folate levels, reticulocyte count, haemoglobin electrophoretic studies and a bone marrow examination. Once the anaemia and its cause have been established, simple guidelines are provided for treating the various abnormalities. A ‘shot gun’ approach is not recommended and may confuse the issue if treatment fails. Defining the type of anaemia means that specific therapy, whether replacement or directed against a defined abnormality, will usually suffice. Failure to obtain the expected response, provided the patient is complying with treatment, requires a review of the history, examination and laboratory results.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weiss G.
        • Goodnough L.T.
        Anaemia of chronic disease.
        N Engl J Med. 2005; 352 (1011–23)
        • Hill A.
        • Richards S.J.
        • Hillmen P.
        Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.
        Br J Haematol. 2007; 137: 181-192
        • Maggio A.
        Light and shadows in the iron chelation treatment of haematological diseases.
        Br J Haematol. 2007; 138: 407-421
        • Goodnough L.T.
        • Marcus R.E.
        The erythropoietic response to erythropoietin in patients with rheumatoid arthritis.
        J Lab Clin Med. 1997; 130: 381-386
        • Littlewood T.J.
        • Alikan R.
        The use of intravenous iron in patients with cancer-related anaemia.
        Br J Haematol. 2008; 141: 751-756
        • BCSH Working Party
        Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.
        BMJ. 1996; 312: 430-434
        • Garvey B.
        Rituximab in the treatment of autoimmune haematological disorders.
        Br J Haematol. 2008; 141: 149-169
        • Hillmen P.
        • Hall C.
        • Marsh J.C.W.
        • et al.
        Effect of Eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemglobinuria.
        N Engl J Med. 2004; 350: 552-559

      Further reading

      1. Hoffbrand A.V. Moss P.A.H. Pettit J.E. Essential haematology. 5th edn. Blackwell Science, Oxford2006
      2. Lichtman M.A. Beutler E. Kipps T.J. Williams’ hematology. 7th edn. McGraw-Hill Medical, New York2006
      Advertisement